- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02744586
Zambia One Love Aim 3 Trial
A Randomized Control Study to Evaluate Novel Interventions to Reduce Risk Factors Associated With HIV, Neglected Tropical and Non-communicable Diseases Among Couples in Zambia
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a randomized control study to evaluate novel interventions to reduce risk factors associated with HIV, neglected tropical and non-communicable diseases among couples in Zambia.
The aim of this study is to determine whether a Strengthening our Vows (SOV) intervention will reduce HIV exposures from concurrent partnership (CP) when compared to the control Good Health Package Plus (GHPP), in addition to couples' voluntary HIV counseling and testing (CVCT), among concordant HIV-negative couples.
Investigators seeks to compare the impact of the SOV intervention and the GHPP intervention on reduction in a composite of risk factors associated with HIV acquisition from concurrent partners, compare the impact of GHPP and SOV on knowledge and use of hygiene and sanitation measures and hypertension and diabetes screening and management, and compare self-reported couples' testing (CVCT) with outside partners in the SOV and GHPP arms.
Couples will receive SOV or GHPP based on the pre-randomization of the clinic which they attend for standard of care HIV counseling and testing. The Strengthening our Vows (SOV) intervention will seek to establish a dialogue or norm where couples will be able to protect each other from HIV infection from outside partners. The Good Health Package Plus (GHPP) intervention focuses on strategies to improve household health related to diarrheal diseases, helminths, schistosomiasis, diabetes, and hypertension.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lusaka, Zambia
- Lusaka Research Site
-
-
Copperbelt
-
Ndola, Copperbelt, Zambia
- Ndola Research Site
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Heterosexual Zambian couples who have undergone CVCT as standard of care in government health clinics in Lusaka and Ndola. Couples must be women 18-45 cohabiting with men 18-65 years old, have cohabited 3 months or greater, are both HIV-negative and are able to attend the scheduled follow-up visits.
- Heterosexual HIV-concordant negative
- Cohabiting at least 3 months
- Both partners at least 18 years of age (women aged 18-45, men aged 18-65)
- Not on antiretroviral therapy including Post Exposure Prophylaxis (PEP) or Pre Exposure Prophylaxis (PrEP)
- Interested in participating
- Able and willing to provide informed consent (literacy is not required)
- Willing to complete interviewer-administered questionnaires on risk factors
- Available for follow-up for the duration of the study
- Willing and able to be contacted via phone or home visit
- Able and willing to provide adequate locator/contact information for retention purposes, and willing to be contacted by the study staff
Exclusion Criteria:
- Presence of any condition that, in the opinion of the investigator or designee, would preclude provision of informed consent, or otherwise interfere with achieving the study objectives
- Either partner HIV-positive or with indeterminate HIV rapid test results
- Attendance to a clinic involved in the opposite arm of the study (i.e., test with partner at a clinic indicated as SOV but attends a clinic indicated as GHPP or vice versa)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Strengthening our Vows (SOV) Group
Participants in the SOV arm will participate in the "Together HIV Free" and "Protecting My Spouse" plans.
|
Participants, led by a counselor, will discuss options to keep HIV from entering their relationship including both sex partners remaining monogamous, using condoms every time they have sex with outside partners, and being tested together with outside partners to ensure they are HIV negative (Together HIV Free Plan). Participants will discuss options in the event of an outside exposure to HIV including abstaining from having sex with their spouse or by using condoms every time they have sex with their spouse until they can be retested for HIV after 30 days (Protecting my Spouse Plan). Participants will be screened for hypertension, diabetes, schistosomiasis, HIV, syphilis, and trichomonas vaginalis and the presence of sperm (women only). Health problems will be treated or referred. Couples will be administered questionnaires that record self-report of sexually transmitted infections, number of outside partners, and reports of sex without a condom with outside partners. |
PLACEBO_COMPARATOR: Good Health Package Plus (GHPP) Group
Participants in the GHPP arm will receive education on the prevention of helminths, schistosomiasis, hypertension, diabetes, and diarrheal diseases through participatory and interactive group sessions.
|
Participants, led by a counselor, will discuss how to prevent, screen, and treat neglected tropical diseases (helminths and schistosomiasis), non-communicable diseases (hypertension and diabetes) and diarrheal diseases through basic hygiene and sanitation.
The facilitator will demonstrate proper handwashing techniques and chlorination of water and discuss diet and lifestyle changes.
Participants will be screened for hypertension, diabetes, schistosomiasis, HIV, syphilis, and trichomonas vaginalis and the presence of sperm (women only).
Health problems will be treated or referred.
Couples will also be administered questionnaires that record self-report of sexually transmitted infections, number of outside partners, and reports of sex without a condom with outside partners.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HIV Incidence Rate
Time Frame: Duration of Study (Up to six months)
|
The number of new laboratory confirmed HIV diagnosis.
|
Duration of Study (Up to six months)
|
Syphilis Incidence Rate
Time Frame: Duration of Study (Up to six months)
|
The number of new laboratory confirmed syphilis diagnosis.
|
Duration of Study (Up to six months)
|
Vaginal Trichomoniasis Incidence Rate
Time Frame: Duration of Study (Up to six months)
|
The number of new laboratory confirmed vaginal trichomoniasis diagnosis.
|
Duration of Study (Up to six months)
|
Number of Self-Reported Sexually Transmitted Infections (STIs)
Time Frame: Duration of Study (Up to six months)
|
The number of self-reported STIs via questionnaire.
|
Duration of Study (Up to six months)
|
Number of Reports of Sex without a Condom with Outside Partners
Time Frame: Duration of Study (Up to six months)
|
The number of reports of sex without using a condom reported via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Number of Reported Outside Partners
Time Frame: Duration of Study (Up to six months)
|
The self-reported number of sexual partners outside of marriage.
|
Duration of Study (Up to six months)
|
Knowledge and use of hygiene and sanitation measures
Time Frame: Duration of Study (Up to six months)
|
Number of participants who show increased knowledge of hygiene and sanitation measures via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Knowledge of hypertension and diabetes screening and management
Time Frame: Duration of Study (Up to six months)
|
Number of participants who show increased knowledge of hypertension and diabetes screening and management via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Number of self-reports of accessing couples' testing (CVCT) with outside partners
Time Frame: Duration of Study (Up to six months)
|
Number of participants who report accessing CVCT services with their outside partners reported via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Efficacy of Chlorine Use
Time Frame: Duration of Study (Up to six months)
|
The number of participants who report a perceived effect of chlorine use via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Perceived Efficacy of Handwashing
Time Frame: Duration of Study (Up to six months)
|
The number of participants who report a perceived effect of handwashing via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Perceived Efficacy of Deworming
Time Frame: Duration of Study (Up to six months)
|
The number of participants who report a perceived effect of deworming via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Perceived Efficacy of Management of Diabetes
Time Frame: Duration of Study (Up to six months)
|
The number of participants who report a perceived effect of management of diabetes via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Perceived Efficacy of Management of Hypertension
Time Frame: Duration of Study (Up to six months)
|
The number of participants who report a perceived effect of management of hypertension via a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Change in Communication between Husband and Wife
Time Frame: Duration of Study (Up to six months)
|
Change in communication between husband and wife dyads regarding exposure to HIV through extramarital sexual behaviors will be measured using a study specific questionnaire.
|
Duration of Study (Up to six months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Susan Allen, MD, MPH, Emory University
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00083001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexually Transmitted Diseases
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingSTI | Sexually Transmitted Disease (STD) | Sexually Transmitted Infection (STI)United States
-
National Institute of Allergy and Infectious Diseases...Terminated
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
University of ChicagoCompletedSexually Transmitted InfectionUnited States
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); MRC/UVRI and LSHTM Uganda Research... and other collaboratorsCompletedSexually Transmitted InfectionUganda
-
Assistance Publique Hopitaux De MarseilleCompletedSexually Transmitted InfectionFrance
-
University of Illinois at ChicagoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHiv | Sexually Transmitted InfectionSouth Africa
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
Chinese University of Hong KongRecruitingGonorrhea | Sexually Transmitted InfectionHong Kong
-
Sagami Rubber Industries Co., Ltd.Essential Access HealthCompletedContraception | Prevention of Sexually Transmitted InfectionsUnited States